IRRAS to Present at Redeye
Stockholm, March 23, 2021 - IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced that company management will present at the Swedish Investment Bank Redeye on March 30 at 4:00 pm-5:00pm CET. Kleanthis G. Xanthopoulos, Ph.D., CEO and Will Martin, President and CCO will present the IRRAS strategy and answer follow up questions. In total the presentation and the Q&A session is estimated to take one hour. A link with an invitation which will be webcast live is presented below. https://www.redeye.se/events/